Use of complementary and alternative medicine in children with asthma.
BACKGROUND
Because of the potential risk of interaction with, and underuse of, conventional medications, it is important to document the prevalence of the use of complementary and alternative medicines (CAMs) in asthmatic children.


OBJECTIVE
To ascertain the prevalence and type of CAMs, and to identify factors associated with their use.


METHODS
A cross-sectional survey of children who presented to the Asthma Centre of The Montreal Children's Hospital (Montreal, Quebec) between 1999 and 2007 was conducted. At the initial consultation, parents completed a questionnaire inquiring, in part, about CAM use. Computerized health records provided information regarding patient characteristics and their condition.


RESULTS
The median age of the 2027 children surveyed was 6.1 years (interquartile range 3.3 to 10.5 years); 58% were male and 59% of children had persistent asthma. The prevalence of CAM use was 13% (95% CI 12% to 15%). Supplemental vitamins (24%), homeopathy (18%) and acupuncture (11%) were the most commonly reported CAMs. Multivariable logistic regression analysis confirmed the association of CAM use with age younger than six years (OR 1.86; 95% CI 1.20 to 2.96), Asian ethnicity (OR 1.89; 95% CI 1.01 to 3.52), episodic asthma (OR 1.88; 95% CI 1.08 to 3.28) and poor asthma control (OR 1.98; 95% CI 1.80 to 3.31).


CONCLUSIONS
The prevalence of reported CAM use among Quebec children with asthma remained modest (13%), with vitamins, homeopathy and acupuncture being the most popular modalities. CAM use was associated with preschool age, Asian ethnicity, episodic asthma and poor asthma control.
Torres-Llenza
Vanessa
V
Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico, USA.
Bhogal
Sanjit
S
Davis
Michael
M
Ducharme
Francine
F
D001249:Asthma / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D000529:Complementary Therapies / Q000706:statistics & numerical data*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D011792:Quebec
J Asthma. 2004 Apr;41(2):131-9
15115165
Pediatrics. 1994 Dec;94(6 Pt 1):811-4
7970994
J Asthma. 2003;40(7):823-7
14626339
J Asthma. 2007 Apr;44(3):169-75
17454333
Ann Allergy Asthma Immunol. 2003 Jun;90(6):611-5
12839318
Respiration. 2006;73(4):457-63
16308544
Cochrane Database Syst Rev. 2000;(2):CD000008
10796465
South Med J. 2005 Sep;98(9):869-75
16217978
J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):789-91
9438488
J Paediatr Child Health. 2002 Jun;38(3):252-7
12047692
Br J Gen Pract. 2001 Nov;51(472):914-6
11761206
CMAJ. 2005 Sep 13;173(6 Suppl):S12-4
16157728
Clin Pediatr (Phila). 2004 May;43(4):367-73
15118780
Ann Pharmacother. 2004 Feb;38(2):220-5
14742754
Curr Probl Pediatr. 1995 Jul;25(6):180-8
8542748
Cochrane Database Syst Rev. 2000;(2):CD000353
10796532
Eur J Pediatr. 2003 May;162(5):334-41
12692715
Thorax. 2003 Apr;58(4):317-21
12668794
Lancet. 2005 Dec 17;366(9503):2081-2; author reply 2083-6
16360779
Arch Dis Child. 2000 Jun;82 Suppl 2:II2-5
10833469
Pediatr Allergy Immunol. 2007 Mar;18(2):160-6
17338790
Arch Pediatr Adolesc Med. 2002 Oct;156(10):1042-4
12361452
Chest. 2001 Nov;120(5):1461-7
11713120
Respir Med. 2003 Apr;97(4):436-8
12693806
Ann Allergy Asthma Immunol. 2004 Aug;93(2 Suppl 1):S45-54
15330011
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001002
15846609